Data & Analytics

A Cambridge firm's novel intracoronary liquid biopsy is creating a high-resolution data map of heart disease, promising a new era of precision medicine.

Spatial Corp's latest software release accelerates digital manufacturing with key updates to interoperability, data preparation, and complex 3D modeling.

A global water leader joins a powerful coalition to protect the $1.4 trillion economy and 40 million people who depend on the drought-stricken Colorado River.

The utility reports strong Q1 profits and customer rate reductions, but faces scrutiny over Diablo Canyon's safety and the immense grid impact of new data centers.

A new research consortium will finally connect dispatcher decisions to real patient outcomes, promising a revolution in emergency response and community safety.

Just one year after its launch, Germany's first fully digital university has topped a major ranking, signaling a new era for higher education.

A new AI-powered skin patch test for psoriasis just got a major US approval, promising to end costly trial-and-error treatments for millions of patients.

Houston-based FINBOA is a double finalist at the Banking Tech Awards, signaling a major industry shift towards automation for compliance and client services.

A new survey reveals a major shift in health IT, with managed services now central to strategy, but urban and rural hospitals are taking different paths.

UK biotech Promatix presented a new AI-driven platform at AACR 2026 that finds thousands of new cancer targets, promising safer, more precise 'smart bomb' drugs.

The medtech giant posts Q1 growth and secures critical EU approvals for new devices, navigating post-pandemic shifts and geopolitical headwinds with strong cash flow.

A new liquid biopsy using viral DNA gets FDA fast-track status, promising to detect liver cancer recurrence more than five months earlier than imaging scans.

A new partnership aims to develop a diagnostic test for a hidden cancer biomarker, potentially unlocking a targeted therapy for patients with grim prognoses.

UnitedHealth Group posted strong Q1 earnings but is shedding members in a bold pivot, divesting globally to double down on US-based AI and tech innovation.

ATCC and the Broad Institute unveil engineered lung cancer cells to decode drug resistance, offering new hope for patients and fueling AI-driven discovery.

A new regenerative development in Missouri plans to power the AI era by creating a self-sufficient ecosystem for energy, water, and compute.

With a successful $191M IPO, Alamar Biosciences is set to revolutionize diagnostics with its ultra-sensitive proteomics platforms.

USAC affirms its hefty dividend amid record Q1 earnings, fueled by an LNG and AI boom. But what do market trends and tax notices mean for investors?

The firm's second consecutive Data Breakthrough Award highlights its success in solving complex, decades-old data challenges for researchers globally.

New data reveals nearly 4 in 10 women lack key vaginal bacteria linked to fertility, sparking a new conversation about an invisible factor in conception.